Skip Nav Destination
Issues
Journal Name Change
Vol. 1-36 (1978-2013) were published under the journal's former title Onkologie.
Oncology Research and Treatment 2022, Vol. 45, No. 4
Research Article
Preliminary Clinical Validation of a Filtration-Based CTC Assay for Tumor Burden and HER2 Status Monitoring in Metastatic Breast Cancer
Subject Area:
Oncology
Oncol Res Treat (2022) 45 (4): 157–165.
https://doi.org/10.1159/000520497
Diagnostic Value of VDR in Bone Metastasis and Prognosis of Patients with Breast Cancer and Expression Correlation between Vitamin D Receptor and Hairless Protein
Subject Area:
Oncology
Pan Ding; XiaoMing Du; LiHui Wan; XueKe Zhao; DeRui Zhang; ZeLing Huang; Ge Cao; XuYang Zhou; YuQin Zheng; YuWen Cao
Oncol Res Treat (2022) 45 (4): 166–177.
https://doi.org/10.1159/000521078
Anticoagulation Practice in Patients with Cancer-Associated Thrombosis: Insights from GeCAT, a German Prospective Registry Study
Subject Area:
Oncology
Robert Klamroth; Marianne Sinn; Christiane Pollich; Sven Bischoff; Anja Lohneis; Ana-Marija Orlovic; Lilianna Wisłocka; Piet Habbel; Maike de Wit; Ernst Späth-Schwalbe; Christian W. Scholz; Hanno Riess
Oncol Res Treat (2022) 45 (4): 178–185.
https://doi.org/10.1159/000521698
Risk and Prognosis of Subsequent Primary Gastric Cancer
Subject Area:
Oncology
Rongrong Wei; Xinyu Du; Jing Wang; Qi Wang; Xiaojie Zhu; Guanghui Xiang; Chuang Nie; Xu Han; Lin Zhu; Haibo Zhou; Yunhe Jia; Wenjing Tian
Oncol Res Treat (2022) 45 (4): 186–196.
https://doi.org/10.1159/000521846
The Preventive Effects of Boron-Based Gel on Radiation Dermatitis in Patients Being Treated for Breast Cancer: A Phase III Randomized, Double-Blind, Placebo-Controlled Clinical Trial
Subject Area:
Oncology
Fikrettin Sahin; Mohammad Bagher Pirouzpanah; Hossein Bijanpour; Mohammad Mohammadzadeh; Reza Eghdam Zamiri; Amir Ghasemi Jangjoo; Behnam Nasiri; Hojjatollah Saboori; Ayşegül Doğan; Selami Demirci; Erhan Ayşan; Ahmet Çağrı Büke; Ali Reza Naseri; Seyed Kazem Shakouri; Dawood Aghamohammadi; Mostafa Alizade-Harakiyan; Farshad Seyed Nejad
Oncol Res Treat (2022) 45 (4): 197–204.
https://doi.org/10.1159/000520363
Review Article
Discoidin Domain Receptor 2: A New Target in Cancer
Subject Area:
Oncology
Oncol Res Treat (2022) 45 (4): 205–215.
https://doi.org/10.1159/000519645
Next-Generation Sequencing of Circulating Tumor DNA Can Optimize Second-Line Treatment in RAS Wild-Type Metastatic Colorectal Cancer after Progression on anti-EGFR Therapy: Time to Rethink Our Approach
Subject Area:
Oncology
Davide Mauri; Konstantinos Kamposioras; Dimitrios Matthaios; Maria Tolia; Ioanna Nixon; Mario Dambrosio; Georgios Zarkavelis; Konstantinos Papadimitriou; Branka Petricevic; Pantelis Kountourakis; Jindrich Kopecky; Cvetka Grašič Kuhar; Lazar Popovic; Nataliya P. Chilingirova; Ramon Andrade De Mello; Natalija Dedić Plavetić; Konstantinos Katsanos; Bianca Mostert; Filippo Alongi; Berardino de Bari; Stefanie Corradini; Eleytherios Kampletsas; Ioanna Gazouli; Stefania Gkoura; Anna-Lea Amylidi; Antonios Valachis
Oncol Res Treat (2022) 45 (4): 216–221.
https://doi.org/10.1159/000521845
Novel Insights from Clinical Practice
PD-1 Blockade Elicits Ongoing Remission in Two Cases of Refractory Microsatellite-Stable Cancer Harboring a POLE Mutation
Subject Area:
Oncology
Oncol Res Treat (2022) 45 (4): 222–226.
https://doi.org/10.1159/000521332
Pharma News
PharmaNews
Subject Area:
Oncology
Oncol Res Treat (2022) 45 (4): 227.
https://doi.org/10.1159/000524287
PharmaNews
Subject Area:
Oncology
Oncol Res Treat (2022) 45 (4): 228–229.
https://doi.org/10.1159/000524286
PharmaNews
Subject Area:
Oncology
Oncol Res Treat (2022) 45 (4): 230–233.
https://doi.org/10.1159/000524106
Society Bulletins
Society Bulletins
Subject Area:
Oncology
Oncol Res Treat (2022) 45 (4): 234–240.
https://doi.org/10.1159/000524288
